|
2024
|
Invention
|
Muscarinic acetylcholine m1 receptor antagonists.
Provided herein are compounds which are useful... |
|
|
Invention
|
Crystalline compound of an lpar1 antagonist. inter aliainter alia, a ciy stall ine compound of an... |
|
2022
|
Invention
|
Lpar1 antagonists and uses thereof.
Described herein, inter alia, are LPAR1 antagonists and uses... |
|
|
Invention
|
Lpar1 antagonists and uses thereof. Described herein, inter alia, are LPAR1 antagonists and uses ... |
|
|
Invention
|
Crystalline compound of muscarinic acetylcholine m1 receptor antagonists.
Disclosed herein, inte... |
|
2020
|
Invention
|
Muscarinic acetylcholine m1 receptor antagonists. 1); synthetic methods for making the compounds;... |
|
|
Invention
|
Muscarinic acetylcholine m1 receptor antagonists.
Provided herein, inter alia, are compounds whi... |
|
2019
|
Invention
|
1 receptor antagonists. Provided, inter alia, are compounds which are useful as antagonists of th... |
|
|
Invention
|
Muscarinic acetylcholine m1 receptor antagonists. Provided herein are compounds which are useful ... |
|
|
Invention
|
1 receptor antagonists. 1); synthetic methods for making the compounds; pharmaceutical compositio... |
|
|
Invention
|
Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders. The pres... |
|
2017
|
Invention
|
Methods of treating cochlear synaptopathy. The present application describes the use of gamma sec... |
